AVADEL PHARMACEUTICALS PLC shareholders Q2 2023

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.6%.

AVADEL PHARMACEUTICALS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Cutler Group LLC / CA 800$130.00%
Citadel Advisors 486,195$8,012,4930.00%
DEUTSCHE BANK AG\ 225,000$3,708,0000.00%
JANE STREET GROUP, LLC 258,050$4,252,6640.00%
GROUP ONE TRADING, L.P. 19,416$319,9760.00%
AMERIPRISE FINANCIAL INC 261,679$4,312,4700.00%
BARCLAYS PLC 49,335$8130.00%
GOLDMAN SACHS GROUP INC 212,799$3,506,9280.00%
MORGAN STANLEY 461,094$7,598,8400.00%
Impact Partnership Wealth, LLC 156$2,5710.00%
Citadel Advisors 251,800$4,149,6640.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 411,500$6,781,5200.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 318,700$5,252,1760.00%
JPMORGAN CHASE & CO 332,624$5,481,6430.00%
OSAIC HOLDINGS, INC. 19,640$323,6630.00%
Steward Partners Investment Advisory, LLC 2,300$37,9040.00%
BALDWIN BROTHERS LLC/MA 500$8,2400.00%
Cetera Advisor Networks LLC 11,792$194,3320.00%
Banque Cantonale Vaudoise 1,000$160.00%
WOLVERINE ASSET MANAGEMENT LLC 5,912$97,4290.00%
External links

This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q2 2023. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.